TY - JOUR
T1 - Host response profile of human brain proteome in toxoplasma encephalitis co-infected with HIV
AU - Sahu, Apeksha
AU - Kumar, Satwant
AU - Sreenivasamurthy, Sreelakshmi K.
AU - Selvan, Lakshmi Dhevi N.
AU - Madugundu, Anil K.
AU - Yelamanchi, Soujanya D.
AU - Puttamallesh, Vinuth N.
AU - Dey, Gourav
AU - Anil, Abhijith K.
AU - Srinivasan, Anand
AU - Mukherjee, Kanchan K.
AU - Gowda, Harsha
AU - Satishchandra, Parthasarathy
AU - Mahadevan, Anita
AU - Pandey, Akhilesh
AU - Prasad, Thottethodi Subrahmanya Keshava
AU - Shankar, Susarla Krishna
N1 - Publisher Copyright:
© 2014 Sahu et al.; licensee BioMed Central Ltd.
PY - 2014
Y1 - 2014
N2 - Background: Toxoplasma encephalitis is caused by the opportunistic protozoan parasite Toxoplasma gondii. Primary infection with T. gondii in immunocompetent individuals remains largely asymptomatic. In contrast, in immunocompromised individuals, reactivation of the parasite results in severe complications and mortality. Molecular changes at the protein level in the host central nervous system and proteins associated with pathogenesis of toxoplasma encephalitis are largely unexplored. We used a global quantitative proteomic strategy to identify differentially regulated proteins and affected molecular networks in the human host during T. gondii infection with HIV co-infection. Results: We identified 3,496 proteins out of which 607 proteins were differentially expressed (≥1.5-fold) when frontal lobe of the brain from patients diagnosed with toxoplasma encephalitis was compared to control brain tissues. We validated differential expression of 3 proteins through immunohistochemistry, which was confirmed to be consistent with mass spectrometry analysis. Pathway analysis of differentially expressed proteins indicated deregulation of several pathways involved in antigen processing, immune response, neuronal growth, neurotransmitter transport and energy metabolism. Conclusions: Global quantitative proteomic approach adopted in this study generated a comparative proteome profile of brain tissues from toxoplasma encephalitis patients co-infected with HIV. Differentially expressed proteins include previously reported and several new proteins in the context of T. gondii and HIV infection, which can be further investigated. Molecular pathways identified to be associated with the disease should enhance our understanding of pathogenesis in toxoplasma encephalitis.
AB - Background: Toxoplasma encephalitis is caused by the opportunistic protozoan parasite Toxoplasma gondii. Primary infection with T. gondii in immunocompetent individuals remains largely asymptomatic. In contrast, in immunocompromised individuals, reactivation of the parasite results in severe complications and mortality. Molecular changes at the protein level in the host central nervous system and proteins associated with pathogenesis of toxoplasma encephalitis are largely unexplored. We used a global quantitative proteomic strategy to identify differentially regulated proteins and affected molecular networks in the human host during T. gondii infection with HIV co-infection. Results: We identified 3,496 proteins out of which 607 proteins were differentially expressed (≥1.5-fold) when frontal lobe of the brain from patients diagnosed with toxoplasma encephalitis was compared to control brain tissues. We validated differential expression of 3 proteins through immunohistochemistry, which was confirmed to be consistent with mass spectrometry analysis. Pathway analysis of differentially expressed proteins indicated deregulation of several pathways involved in antigen processing, immune response, neuronal growth, neurotransmitter transport and energy metabolism. Conclusions: Global quantitative proteomic approach adopted in this study generated a comparative proteome profile of brain tissues from toxoplasma encephalitis patients co-infected with HIV. Differentially expressed proteins include previously reported and several new proteins in the context of T. gondii and HIV infection, which can be further investigated. Molecular pathways identified to be associated with the disease should enhance our understanding of pathogenesis in toxoplasma encephalitis.
KW - Chronic meningitis
KW - Immunosuppression
KW - LTQ-Orbitrap Velos
KW - Neuroinfections
KW - Opportunistic infections
KW - iTRAQ labeling
UR - http://www.scopus.com/inward/record.url?scp=84912552058&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84912552058&partnerID=8YFLogxK
U2 - 10.1186/1559-0275-11-39
DO - 10.1186/1559-0275-11-39
M3 - Article
AN - SCOPUS:84912552058
SN - 1542-6416
VL - 11
JO - Clinical Proteomics
JF - Clinical Proteomics
IS - 1
ER -